|By PR Newswire||
|February 4, 2014 03:18 PM EST||
Parabase Genomics and the UCLA Clinical Genomics Center Selected as Pilot Partners
ALISO VIEJO, Calif., Feb. 04, 2014 /PRNewswire-USNewswire/ -- Eight years. That's the average amount of time patients wait to receive an official medical diagnosis when facing a rare genetic disease. The stress this medical diagnostic process places on families can be devastating. This year, undiagnosed rare disease patients will receive a gift of hope through an innovative whole genome sequencing pilot program developed and funded by Global Genes in partnership with SWAN USA (Syndromes Without A Name).
The collaborative agreement between Global Genes and SWAN USA will allow undiagnosed rare disease patients who cannot afford costly genomic testing – which can range from $3,500 to more than $5,000 per test - to obtain free clinical genomic sequencing testing to aid in finding the genetic source of their mysterious illnesses. Boston-based Parabase Genomics and the UCLA Clinical Genomics Center have been selected as the first clinical genomic sequencing providers for the pilot project.
Starting March 1, 2014, approximately 30 undiagnosed patients will undergo free whole exome sequencing, funded by Global Genes through a donor directed fund launched last September at the 2nd Annual Tribute to Champions of Hope event. With additional funding underway, the program is expected to expand and include more undiagnosed patients.
"We are thrilled to be working with leading genomic sequencing providers on both coasts to help patients in our community find diagnoses for their rare and genetic diseases," said Andrea Epstein, Executive Director, Global Genes. "We talk to patients, parent advocates and families every day who have had the misfortune of receiving up to three misdiagnoses and are facing diseases that have eluded medical professionals for years due to lack of access to the most cutting edge testing techniques."
Global Genes established a multi-disciplinary committee and a formal Request for Proposal process to select Parabase Genomics and UCLA's Clinical Genomics Center as the initial genomic sequencing partners for the pilot project. This committee reflected a diverse group of rare and genetic disease stakeholders including parent advocates, patient foundation leaders, clinical advisors and Global Genes executives. The team included Amy Clugston, Founder of SWAN USA, Caroline Loewy, EVP and CFO Tobira Therapeutics and parent advocate, Cristy Spooner, parent advocate, Gary Jackson PhD, Genetics and Technology Consultant, Heather Long, Founder of U.R. Our Hope, Nicole Boice, President, Global Genes and Andrea Epstein, Executive Director, Global Genes.
Global Genes' partner on the project, SWAN USA, is equally enthusiastic about the potential effect on families that this genetic testing will bring.
"Families face an incredible emotional and economic hardship as they struggle to find a proper diagnosis for their loved ones disease," said Amy Clugston, Founder and President, SWAN USA. "To be a part of this innovative program and have the capacity to aid families locate the resources they need is exactly our goal."
Helping to make this technology a reality for undiagnosed patients is Boston-based Parabase Genomics and the UCLA Clinical Genomics Center based in Los Angeles.
"It's our pleasure to join this circle of passionate advocates and experts by providing a timely diagnosis to these deserving patients and their families," said Andy Bhattachariee, PhD, CEO and Scientific Director of Parabase. "In 2014, we look forward to helping these families, and others, with our LifeTime RareDx Test. One of the challenges with translation of next-generation sequencing to newborns and children is the long time it takes to get results. We have developed a complete workflow from blood to a medical report in 2-4 weeks, and our plan is to shorten this timeline to a few days."
The UCLA Clinical Genomics Center also shared their enthusiasm as the West Coast sequencing provider in this new collaborative program. "We are honored and pleased to partner with Global Genes and SWAN USA to accelerate the diagnosis of those affected by rare and genetic diseases," added Dr. Stan Nelson, Professor, Department of Human Genetics, UCLA.
About Global Genes
Global Genes is a leading rare and genetic disease patient advocacy organization. The organization mission is to 'Eliminate the Challenges of Rare Disease', by equipping patients to become successful advocates, and through education and empowerment, become 'activists' for their disease. Global Genes does this through a growing portfolio of educational tools and resources, events, building out critical connections and funding innovations in science and technology that will impact patients within their lifetime. Recognized worldwide by the Blue Denim Genes Ribbon™, Global Genes unites experts, advocates and patients of all ages to stand together in hope for treatments and cures for the estimated 7,000 rare and genetic diseases that impact approximately 30 million Americans and over 250 million people worldwide. For more information about Global Genes™, please visit the following links:
- Web: http://globalgenes.org/
- Facebook: https://www.facebook.com/globalgenesproject?ref=br_tf
- Twitter: @GlobalGenes - https://twitter.com/GlobalGenes
About SWAN USA
SWAN USA is a non-profit tax exempt organization that offers support, information and advice to families of children living with an undiagnosed condition – or a syndrome without a name. The organization offers support, advice and information on the challenges that families face when there is no diagnosis and advocates for changes in the medical community that will benefit undiagnosed individuals. To learn more about SWAN USA, visit www.undiagnosed-usa.org.
About Parabase Genomics
Parabase Genomics is a privately held molecular diagnostics company focused on changing the way newborns and children with genetic disorders are diagnosed and treated. The Company's LifeTime Tests™ are the first commercially available services that provide a rapid non-invasive method for sample collection and diagnosis of genetic conditions using dried blood spots. This proprietary genetic and informational platform generates actionable information about a newborn's disease profile. Physicians can now avoid delays and adverse consequences by running one single test that is equivalent to several hundred parallel diagnostic tests commonly used today. To learn more, visit http://www.parabasegenomics.com.
About the UCLA Clinical Genomics Center
With expertise in Pediatrics, Human Genetics, and Pathology, the UCLA Clinical Genomics Center provides a comprehensive analysis and diagnostic interpretation of a patient's entire protein-encoding genome by searching through 37 million base pairs in 20,000 genes to potentially locate the single DNA change responsible for the patient's disorder. The Center, part of the David Geffen School of Medicine at UCLA, utilizes next generation sequencing technology, state-of-the-art computational and bioinformatic resources, and integrated laboratory information systems to deliver a precise genetic diagnosis for the benefit of patients and physicians. To learn more, visit: http://pathology.ucla.edu.
SOURCE Global Genes
New competitors, disruptive technologies, and growing expectations are pushing every business to both adopt and deliver new digital services. This ‘Digital Transformation’ demands rapid delivery and continuous iteration of new competitive services via multiple channels, which in turn demands new service delivery techniques – including DevOps. In this power panel at @DevOpsSummit 20th Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, panelists will examine how DevOps helps to meet th...
Apr. 25, 2017 12:30 PM EDT Reads: 1,120
SYS-CON Events announced today that Hitachi, the leading provider the Internet of Things and Digital Transformation, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Hitachi Data Systems, a wholly owned subsidiary of Hitachi, Ltd., offers an integrated portfolio of services and solutions that enable digital transformation through enhanced data management, governance, mobility and analytics. We help globa...
Apr. 25, 2017 12:15 PM EDT Reads: 902
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain.
Apr. 25, 2017 12:15 PM EDT Reads: 2,497
@DevOpsSummit has been named the ‘Top DevOps Influencer' by iTrend. iTred processes millions of conversations, tweets, interactions, news articles, press releases, blog posts - and extract meaning form them and analyzes mobile and desktop software platforms used to communicate, various metadata (such as geo location), and automation tools. In overall placement, @DevOpsSummit ranked as the number one ‘DevOps Influencer' followed by @CloudExpo at third, and @MicroservicesE at 24th.
Apr. 25, 2017 12:00 PM EDT Reads: 2,697
SYS-CON Events announced today that T-Mobile will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. As America's Un-carrier, T-Mobile US, Inc., is redefining the way consumers and businesses buy wireless services through leading product and service innovation. The Company's advanced nationwide 4G LTE network delivers outstanding wireless experiences to 67.4 million customers who are unwilling to compromise on ...
Apr. 25, 2017 12:00 PM EDT Reads: 843
The goal of Continuous Testing is to shift testing left to find defects earlier and release software faster. This can be achieved by integrating a set of open source functional and performance testing tools in the early stages of your software delivery lifecycle. There is one process that binds all application delivery stages together into one well-orchestrated machine: Continuous Testing. Continuous Testing is the conveyor belt between the Software Factory and production stages. Artifacts are ...
Apr. 25, 2017 11:30 AM EDT Reads: 1,044
All organizations that did not originate this moment have a pre-existing culture as well as legacy technology and processes that can be more or less amenable to DevOps implementation. That organizational culture is influenced by the personalities and management styles of Executive Management, the wider culture in which the organization is situated, and the personalities of key team members at all levels of the organization. This culture and entrenched interests usually throw a wrench in the work...
Apr. 25, 2017 11:30 AM EDT Reads: 260
SYS-CON Events announced today that Juniper Networks (NYSE: JNPR), an industry leader in automated, scalable and secure networks, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Juniper Networks challenges the status quo with products, solutions and services that transform the economics of networking. The company co-innovates with customers and partners to deliver automated, scalable and secure network...
Apr. 25, 2017 11:30 AM EDT Reads: 4,807
Quickly find the root cause of complex database problems slowing down your applications. Up to 88% of all application performance issues are related to the database. DPA’s unique response time analysis shows you exactly what needs fixing - in four clicks or less. Optimize performance anywhere. Database Performance Analyzer monitors on-premises, on VMware®, and in the Cloud, including Amazon® AWS and Azure™ virtual machines.
Apr. 25, 2017 11:30 AM EDT Reads: 1,783
The age of Digital Disruption is evolving into the next era – Digital Cohesion, an age in which applications securely self-assemble and deliver predictive services that continuously adapt to user behavior. Information from devices, sensors and applications around us will drive services seamlessly across mobile and fixed devices/infrastructure. This evolution is happening now in software defined services and secure networking. Four key drivers – Performance, Economics, Interoperability and Trust ...
Apr. 25, 2017 11:30 AM EDT Reads: 252
Back in February of 2017, Andrew Clay Schafer of Pivotal tweeted the following: “seriously tho, the whole software industry is stuck on deployment when we desperately need architecture and telemetry.” Intrigue in a 140 characters. For me, I hear Andrew saying, “we’re jumping to step 5 before we’ve successfully completed steps 1-4.”
Apr. 25, 2017 11:15 AM EDT Reads: 1,601
Five years ago development was seen as a dead-end career, now it’s anything but – with an explosion in mobile and IoT initiatives increasing the demand for skilled engineers. But apart from having a ready supply of great coders, what constitutes true ‘DevOps Royalty’? It’ll be the ability to craft resilient architectures, supportability, security everywhere across the software lifecycle. In his keynote at @DevOpsSummit at 20th Cloud Expo, Jeffrey Scheaffer, GM and SVP, Continuous Delivery Busine...
Apr. 25, 2017 10:30 AM EDT Reads: 630
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
Apr. 25, 2017 10:30 AM EDT Reads: 373
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
Apr. 25, 2017 10:15 AM EDT Reads: 2,093
The 20th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held June 6-8, 2017, at the Javits Center in New York City, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Containers, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportunity. Submit your speaking proposal ...
Apr. 25, 2017 10:00 AM EDT Reads: 943